Related Experiment Video
Updated: Jul 19, 2025
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
562
Deep learning prediction model for central lymph node metastasis in papillary thyroid microcarcinoma based on
Wenhao Ren1, Yanli Zhu1, Qian Wang1
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital and Institute, Beijing, China.
Cancer Science
|August 14, 2023
Summary
A deep learning model accurately predicts lymph node metastasis in papillary thyroid microcarcinoma (PTMC) using fine-needle aspiration (FNA) samples. This AI approach offers a more reliable preoperative assessment than traditional methods, aiding treatment decisions for PTMC.
Area of Science:
- Oncology
- Artificial Intelligence in Medicine
- Pathology
Background:
- Accurate preoperative assessment of lymph node status is crucial for managing low-risk papillary thyroid microcarcinoma (PTMC), where clinical evaluation is often inaccurate.
- The decision between surgery and active surveillance for PTMC is complicated by uncertainties in lymph node metastasis prediction.
Purpose of the Study:
- To develop and validate a deep learning model for predicting central lymph node metastases in PTMC based on preoperative fine-needle aspiration (FNA) liquid-based preparations.
- To compare the predictive performance of the deep learning model against traditional clinical evaluation methods.
Main Methods:
- A deep learning model was trained using 208 preoperative FNA liquid-based preparations from PTMC patients who underwent lymph node dissection.
- The model predicted central lymph node metastases, and its performance was evaluated using sensitivity, specificity, PPV, NPV, accuracy, and AUC.
- Key cell morphologies influencing the model's predictions were identified through further analysis.
Main Results:
- The deep learning model achieved a sensitivity of 78.9%, specificity of 73.9%, PPV of 71.4%, NPV of 81.0%, and accuracy of 76.2%.
- The area under the ROC curve (AUC) was 0.8503, indicating strong predictive capability.
- The model's predictive performance was found to be superior to traditional clinical evaluation methods.
Conclusions:
- Deep learning models utilizing preoperative thyroid FNA liquid-based preparations represent a reliable strategy for predicting central lymph node metastases in PTMC.
- This AI-driven approach offers improved accuracy over conventional clinical assessments, potentially refining treatment strategies for PTMC patients.
